{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:57:55Z","timestamp":1793829475522,"version":"4.6.1"},"reference-count":207,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T00:00:00Z","timestamp":1692576000000},"content-version":"vor","delay-in-days":1054,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s13311-020-00897-4","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T10:03:55Z","timestamp":1597313035000},"page":"1464-1479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Autonomic Dysfunction in Parkinson's Disease"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9517-7295","authenticated-orcid":false,"given":"Ronald F.","family":"Pfeiffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1007\/s13311-020-00897-4_bib1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1353-8020(01)00052-9","article-title":"Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey","volume":"8","author":"Siddiqui","year":"2002","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e31827deb74","article-title":"The spectrum of nonmotor symptoms in early Parkinson disease","volume":"80","author":"Khoo","year":"2013","journal-title":"Neurology"},{"key":"10.1007\/s13311-020-00897-4_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.parkreldis.2019.07.008","article-title":"Longitudinal assessment of autonomic dysfunction in early Parkinson's disease","volume":"66","author":"Stankovi\u0107","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"10.1007\/s13311-020-00897-4_bib4","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jamaneurol.2017.1125","article-title":"Association of autonomic dysfunction with disease progression and survival in Parkinson disease","volume":"74","author":"De Pablo-Fernandez","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1007\/s13311-020-00897-4_bib5","doi-asserted-by":"crossref","first-page":"101807","DOI":"10.1016\/j.artmed.2020.101807","article-title":"Prognostic factors of rapid symptoms progression in patients with newly diagnosed Parkinson's disease","volume":"103","author":"Tsiouris","year":"2020","journal-title":"Artif Intell Med"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/mds.22172","article-title":"Lesions outside the CNS in Parkinson's disease","volume":"24","author":"Djaldetti","year":"2009","journal-title":"Mov Disord"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/mds.22260","article-title":"Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation \u2013 critique and recommendations by Movement Disorders Task Force on Rating Scales for Parkinson's Disease","volume":"24","author":"Evatt","year":"2009","journal-title":"Mov Disord"},{"issue":"11","key":"10.1007\/s13311-020-00897-4_bib8","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/mds.23742","article-title":"The Movement Disorders Task Force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension","volume":"26","author":"Pavy-Le Traon","year":"2011","journal-title":"Mov Disord"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/mdc3.12636","article-title":"Clinical rating scales for urinary symptoms in Parkinson's disease: critique and recommendations","volume":"5","author":"Pavy-Le Traon","year":"2018","journal-title":"Mov Disord Clin Pract"},{"issue":"9-10","key":"10.1007\/s13311-020-00897-4_bib10","first-page":"27","article-title":"Movement Disorders Society's Unified Parkinson's Disease Rating Scale and nonmotor scales in patients with Parkinson's disease","volume":"16","author":"Driver-Dunckley","year":"2019","journal-title":"Innov Clin Neurosci"},{"key":"10.1007\/s13311-020-00897-4_bib11","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S1353-8020(11)70117-1","article-title":"Facilitating clinical research: the National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Common Data Elements project","volume":"18S2","author":"Tanner","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"10.1007\/s13311-020-00897-4_bib12","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(03)00555-6","article-title":"Dysautonomia in Parkinson's disease: neurocardiological abnormalities","volume":"2","author":"Goldstein","year":"2003","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1750-3639.2005.tb00097.x","article-title":"Profound cardiac sympathetic denervation occurs in Parkinson disease","volume":"15","author":"Amino","year":"2005","journal-title":"Brain Pathol"},{"issue":"Suppl 2","key":"10.1007\/s13311-020-00897-4_bib14","first-page":"S732","article-title":"123I-Metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders","volume":"24","author":"Rascol","year":"2009","journal-title":"Mov Disord"},{"issue":"8","key":"10.1007\/s13311-020-00897-4_bib15","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.parkreldis.2008.01.010","article-title":"Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy","volume":"14","author":"Goldstein","year":"2008","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib16","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.parkreldis.2012.01.009","article-title":"123I-MIBG myocardial scintigraphy for differentiating Parkinson's disease from other neurodegenerative parkinsonism: a systematic review and meta-analysis","volume":"18","author":"Orimo","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.parkreldis.2008.04.031","article-title":"Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease","volume":"15","author":"Haensch","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00897-4_bib18","first-page":"805351","article-title":"Myocardial (123)I-MIBG uptake and cardiovascular autonomic function in Parkinson's disease","volume":"2015","author":"Katagiri","year":"2015","journal-title":"Parkinsons Dis"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib19","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","article-title":"Consensus statement on the definition of orthostatic hypotension, neutrally mediated syncope and the postural tachycardia syndrome","volume":"21","author":"Freeman","year":"2011","journal-title":"Clin Auton Res"},{"key":"10.1007\/s13311-020-00897-4_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40120-019-00152-9","article-title":"Neurogenic orthostatic hypotension in Parkinson disease: a primer","volume":"8","author":"Cutsforth-Gregory","year":"2019","journal-title":"Neurol Ther"},{"key":"10.1007\/s13311-020-00897-4_bib21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cger.2019.09.002","article-title":"Orthostatic hypotension in Parkinson disease","volume":"36","author":"Palma","year":"2020","journal-title":"Clin Geriatr Med"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib22","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/HJH.0000000000001265","article-title":"Optimal diagnostic thresholds for diagnosis of orthostatic hypotension with a \u201csit-to-stand test.\u201d","volume":"35","author":"Shaw","year":"2017","journal-title":"J Hypertens"},{"key":"10.1007\/s13311-020-00897-4_bib23","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/WNL.0000000000002030","article-title":"Clinical implications of delayed orthostatic hypotension","volume":"85","author":"Gibbons","year":"2015","journal-title":"Neurology"},{"key":"10.1007\/s13311-020-00897-4_bib24","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00415-016-8375-x","article-title":"The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension","volume":"264","author":"Gibbons","year":"2017","journal-title":"J Neurol"},{"issue":"10","key":"10.1007\/s13311-020-00897-4_bib25","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.parkreldis.2011.04.016","article-title":"Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis","volume":"17","author":"Velseboer","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.14802\/jmd.16001","article-title":"Cardiovascular autonomic dysfunction in mild and advanced Parkinson's disease","volume":"9","author":"Kim","year":"2016","journal-title":"J Mov Disord"},{"key":"10.1007\/s13311-020-00897-4_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jns.2016.09.036","article-title":"Cardiovascular dysfunction in untreated Parkinson's disease: a multi-modality assessment","volume":"370","author":"Strano","year":"2016","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib28","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/jnnp.63.5.584","article-title":"Prevalence of orthostatic hypotension in Parkinson's disease","volume":"63","author":"Senard","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1007\/s13311-020-00897-4_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.parkreldis.2016.09.013","article-title":"Orthostatic hypotension in Parkinson's disease: does it matter if asymptomatic?","volume":"33","author":"Merola","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00897-4_bib30","doi-asserted-by":"crossref","unstructured":"Quarracino C, Otero-Losada M, Capani F, P\u00e9rez-Lloret S. Prevalence and factors related to orthostatic syndromes in recently diagnosed, drug na\u00efve patients with Parkinson disease. Clin Auton Res 2019; https:\/\/doi.org\/10.1007\/s10286-019-00652-6","DOI":"10.1007\/s10286-019-00652-6"},{"issue":"10","key":"10.1007\/s13311-020-00897-4_bib31","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00702-015-1396-2","article-title":"Falls in ambulatory non-demented patients with Parkinson's disease","volume":"122","author":"Rascol","year":"2015","journal-title":"J Neural Transm (Vienna)"},{"issue":"9","key":"10.1007\/s13311-020-00897-4_bib32","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(16)30079-5","article-title":"Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets","volume":"15","author":"Espay","year":"2016","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1152\/jappl.1972.32.2.213","article-title":"Importance of the splanchnic vascular bed in human blood pressure regulation","volume":"32","author":"Rowell","year":"1972","journal-title":"J Appl Physiol"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib34","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.apmr.2014.10.012","article-title":"Effects of patient-controlled abdominal compression on standing systolic blood pressure in adults with orthostatic hypotension","volume":"96","author":"Figueroa","year":"2015","journal-title":"Arch Phys Med Rehabil"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3988\/jcn.2015.11.3.220","article-title":"Orthostatic hypotension: mechanisms, causes, management","volume":"11","author":"Low","year":"2015","journal-title":"J Clin Neurol"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib36","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/hrt.76.6.507","article-title":"Fludrocortisone in the treatment of hypotensive disorders in the elderly","volume":"76","author":"Hussain","year":"1996","journal-title":"Heart"},{"issue":"12","key":"10.1007\/s13311-020-00897-4_bib37","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/1060028018786954","article-title":"Standing and supine blood pressure outcomes associated with droxidopa and midodrine in patients with neurogenic orthostatic hypotension: a Bayesian meta-analysis and mixed treatment comparison of randomized trials","volume":"52","author":"Chen","year":"2018","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib38","first-page":"76","article-title":"Midodrine. A review of its therapeutic use in the management of orthostatic hypotension","volume":"12","author":"McClellan","year":"1998","journal-title":"Drugs Aging"},{"issue":"10","key":"10.1007\/s13311-020-00897-4_bib39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jash.2016.07.009","article-title":"Effects of the novel norepinephrine prodrug, droxidopa, on ambulatory blood pressure in patients with neurogenic orthostatic hypotension","volume":"10","author":"Kaufmann","year":"2016","journal-title":"J Am Soc Hypertens"},{"issue":"Suppl 1","key":"10.1007\/s13311-020-00897-4_bib40","first-page":"1","article-title":"Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?","volume":"27","author":"Kaufmann","year":"2017","journal-title":"Clin Auton Res"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/WNN.0000000000000198","article-title":"Cognitive and behavioral changes in patients treated with droxidopa for neurogenic orthostatic hypotension: a retrospective review","volume":"32","author":"McDonell","year":"2019","journal-title":"Cogn Behav Neurol"},{"issue":"1-2","key":"10.1007\/s13311-020-00897-4_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2011.06.047","article-title":"Mechanisms of orthostatic hypotension and supine hypertension in Parkinson's disease","volume":"310","author":"Sharabi","year":"2011","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1080\/08037050310011821","article-title":"Circadian blood pressure pattern and cognitive function in newly diagnosed older hypertensives","volume":"12","author":"Cicconetti","year":"2003","journal-title":"Blood Press"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ejcnurse.2006.05.001","article-title":"Nondipping blood pressure patterns among individuals with essential hypertension: a review of the literature","volume":"6","author":"Routledge","year":"2007","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"4","key":"10.1007\/s13311-020-00897-4_bib45","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10286-018-0529-8","article-title":"Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS)","volume":"28","author":"Fanciulli","year":"2018","journal-title":"Clin Auton Res"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10286-015-0336-4","article-title":"Supine hypertension in Parkinson's disease and multiple system atrophy","volume":"26","author":"Fanciulli","year":"2016","journal-title":"Clin Auton Res"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10286-015-0324-8","article-title":"Clinical characteristics of supine hypertension in de novo Parkinson disease","volume":"26","author":"Umehara","year":"2016","journal-title":"Clin Auton Res"},{"issue":"12","key":"10.1007\/s13311-020-00897-4_bib48","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/ajh\/hpy089","article-title":"Orthostatic hypotension in the hypertensive patient","volume":"31","author":"Biaggioni","year":"2018","journal-title":"Am J Hypertens"},{"key":"10.1007\/s13311-020-00897-4_bib49","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1161\/HYPERTENSIONAHA.107.105171","article-title":"Excessive nitric oxide function and blood pressure regulation in patients with autonomic failure","volume":"51","author":"Gamboa","year":"2008","journal-title":"Hypertension"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/mds.870060211","article-title":"Gastrointestinal symptoms in Parkinson's disease","volume":"6","author":"Edwards","year":"1991","journal-title":"Mov Disord"},{"issue":"4","key":"10.1007\/s13311-020-00897-4_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1212\/01.wnl.0000266593.50534.e8","article-title":"Patient-reported autonomic symptoms in Parkinson disease","volume":"69","author":"Verbaan","year":"2007","journal-title":"Neurology"},{"key":"10.1007\/s13311-020-00897-4_bib52","doi-asserted-by":"crossref","unstructured":"van Wamelen DJ, Leta V, Johnson J, et al. Drooling in Parkinson's disease: prevalence and progression from the Non-motor International Longitudinal Study. Dysphagia 2020; https:\/\/doi.org\/10.1007\/s00455-020-10102-5.","DOI":"10.1007\/s00455-020-10102-5"},{"issue":"12","key":"10.1007\/s13311-020-00897-4_bib53","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s10072-016-2708-5","article-title":"Pathophysiology underlying drooling in Parkinson's disease: oropharyngeal bradykinesia","volume":"37","author":"Karakoc","year":"2016","journal-title":"Neurol Sci"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib54","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/mds.10276","article-title":"Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study","volume":"17","author":"Hyson","year":"2002","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-020-00897-4_bib55","doi-asserted-by":"crossref","unstructured":"Isaacson SH, Ondo W, Jackson CE, et al. Safety and efficacy of rimabotulinumtoxinB for treatment of sialorrhea in adults. A randomized clinical trial. JAMA Neurol 2020; https:\/\/doi.org\/10.1001\/jamaneurol.2019.4565","DOI":"10.1001\/jamaneurol.2019.4565"},{"key":"10.1007\/s13311-020-00897-4_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.parkreldis.2019.11.024","article-title":"Long-term incobotulinumtoxinA treatment for chronic sialorrhea: efficacy and safety over 64 weeks","volume":"70","author":"Jost","year":"2020","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00897-4_bib57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2016.07.001","article-title":"Drooling in Parkinson's disease: a randomized controlled trial of incobotulinum toxin A and a meta-analysis of botulinum toxins","volume":"30","author":"Narayanaswami","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1212\/01.WNL.0000101713.81253.4C","article-title":"A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease","volume":"62","author":"Ondo","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib59","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.parkreldis.2010.08.003","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"17","author":"Pfeiffer","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00897-4_bib60","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.parkreldis.2011.11.006","article-title":"Prevalence of oropharyngeal dysphagia in Parkinson's disease: a meta-analysis","volume":"18","author":"Kalf","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib61","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JPD-150687","article-title":"Multimodal swallowing evaluation with high-resolution manometry reveals subtle swallowing changes in early and mid-stage Parkinson disease","volume":"6","author":"Jones","year":"2016","journal-title":"J Parkinsons Dis"},{"issue":"4","key":"10.1007\/s13311-020-00897-4_bib62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4103\/aian.AIAN_349_18","article-title":"Prevalence of malnutrition in Parkinson's disease and correlation with gastrointestinal symptoms","volume":"22","author":"Paul","year":"2019","journal-title":"Ann Indian Acad Neurol"},{"key":"10.1007\/s13311-020-00897-4_bib63","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2019.02.043","article-title":"Dysphagia predicts poor outcome in late-stage Parkinson's disease","volume":"64","author":"Fabbri","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00897-4_bib64","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.parkreldis.2019.02.002","article-title":"Pill swallowing in Parkinson's disease: a prospective study based on flexible endoscopic evaluation of swallowing","volume":"62","author":"Buhmann","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00897-4_bib65","series-title":"Parkinson's disease","first-page":"309","article-title":"Gastrointestinal dysfunction in Parkinson's disease","author":"Pfeiffer","year":"2013"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib66","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00455-007-9113-4","article-title":"The coordination of breathing and swallowing in Parkinson's disease","volume":"23","author":"Gross","year":"2008","journal-title":"Dysphagia"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib67","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004836-199407000-00004","article-title":"Gastrointestinal dysfunction in Parkinson's disease. A report of clinical experience at a single center","volume":"19","author":"Byrne","year":"1994","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib68","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00455-015-9671-9","article-title":"Dysphagia in Parkinson's disease","volume":"31","author":"Suttrup","year":"2016","journal-title":"Dysphagia"},{"key":"10.1007\/s13311-020-00897-4_bib69","doi-asserted-by":"crossref","unstructured":"Curtis JA, Troche MS. Handheld cough testing: a novel tool for cough assessment and dysphagia screening. Dysphagia 2020; https:\/\/doi.org\/10.1007\/s00455-020-10097-z.","DOI":"10.1007\/s00455-020-10097-z"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib70","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2710.2009.01031.x","article-title":"Does levodopa improve swallowing dysfunction in Parkinson's disease patients?","volume":"34","author":"Menezes","year":"2009","journal-title":"J Clin Pharm Ther"},{"key":"10.1007\/s13311-020-00897-4_bib71","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.parkreldis.2016.04.034","article-title":"Levodopa responsiveness of dysphagia in advanced Parkinson's disease and reliability testing of the FEES-levodopa-test","volume":"28","author":"Warnecke","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00897-4_bib72","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2019.07.003","article-title":"Effects of the rotigotine transdermal patch versus oral levodopa on swallowing in patients with Parkinson's disease","volume":"404","author":"Hirano","year":"2019","journal-title":"J Neurol Sci"},{"issue":"21","key":"10.1007\/s13311-020-00897-4_bib73","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1212\/WNL.0b013e3181fef115","article-title":"Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial","volume":"75","author":"Troche","year":"2010","journal-title":"Neurology"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib74","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1589\/jpts.28.1840","article-title":"Effect of simultaneous application of postural techniques and expiratory muscle strength training on the enhancement of the swallowing function of patients with dysphagia caused by Parkinson's disease","volume":"28","author":"Byeon","year":"2016","journal-title":"J Phys Ther Sci"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib75","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1044\/2019_JSLHR-19-00207","article-title":"Respiratory-swallow coordination training and voluntary cough skill training: a single-subject treatment study in a person with Parkinson's disease","volume":"63","author":"Curtis","year":"2020","journal-title":"J Speech Lang Hear Res"},{"key":"10.1007\/s13311-020-00897-4_bib76","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jns.2017.11.015","article-title":"Effect of Lee Silverman Voice Treatment (LSVT-LOUD\u00ae) on swallowing and cough in Parkinson's disease: a pilot study","volume":"383","author":"Miles","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-020-00897-4_bib77","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00701-019-04182-y","article-title":"The effects of chronic subthalamic stimulation on nonmotor symptoms in advanced Parkinson's disease, revealed by an online questionnaire program","volume":"162","author":"Kawaguchi","year":"2020","journal-title":"Acta Neurochir"},{"key":"10.1007\/s13311-020-00897-4_bib78","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jns.2018.08.016","article-title":"Persistent adverse effects following different targets and periods after bilateral deep brain stimulation in patients with Parkinson's disease","volume":"393","author":"Yin","year":"2018","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib79","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/1545968319847968","article-title":"The effect of high-frequency repetitive transcranial magnetic stimulation on advancing Parkinson's disease with dysphagia: double blind randomized clinical trial","volume":"33","author":"Khedr","year":"2019","journal-title":"Neurorehabil Neural Repair"},{"issue":"15","key":"10.1007\/s13311-020-00897-4_bib80","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM200204113461517","article-title":"Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease","volume":"346","author":"Restivo","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib81","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mds.870110110","article-title":"Cricopharyngeal dysfunction in Parkinson's disease: role in dysphagia and response to myotomy","volume":"11","author":"Born","year":"1996","journal-title":"Mov Disord"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gtc.2014.11.001","article-title":"Gastroparesis: definitions and diagnosis","volume":"44","author":"Pasricha","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib83","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.parkreldis.2011.12.004","article-title":"Gastroparesis and Parkinson's disease: a systematic review","volume":"18","author":"Heetun","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00897-4_bib84","doi-asserted-by":"crossref","unstructured":"Su A, Gandhy R, Barlow C, Triadafilopuolos G. Utility of the wireless motility capsule and lactulose breath testing in the evaluation of patients with Parkinson's disease who present with functional gastrointestinal symptoms. BMJ Open Gastroenterol 2017;4: https:\/\/doi.org\/10.1136\/bmjgast-2017-000132.","DOI":"10.1136\/bmjgast-2017-000132"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib85","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00415-010-5769-z","article-title":"Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson's disease? An analysis using the 13C-acetate breath test","volume":"258","author":"Tanaka","year":"2011","journal-title":"J Neurol"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib86","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/mds.870120618","article-title":"Effect of chronic oral domperidone therapy on gastrointestinal symptoms and gastric emptying in patients with Parkinson's disease","volume":"12","author":"Soykan","year":"1997","journal-title":"Mov Disord"},{"issue":"4","key":"10.1007\/s13311-020-00897-4_bib87","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/WNF.0b013e3182575cdb","article-title":"Coadministration of domperidone increases plasma levodopa concentration in patients with Parkinson disease","volume":"35","author":"Nishikawa","year":"2012","journal-title":"Clin Neuropharmacol"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib88","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s40261-015-0360-0","article-title":"Domperidone and risk of ventricular arrhythmia and cardiac death: a systematic review and meta-analysis","volume":"36","author":"Leelakanok","year":"2016","journal-title":"Clin Drug Investig"},{"issue":"1416","key":"10.1007\/s13311-020-00897-4_bib89","first-page":"66","article-title":"Domperidone safety: a mini-review of the science of QT prolongation and clinical implications of recent global regulatory recommendations","volume":"128","author":"Buffery","year":"2015","journal-title":"N Z Med J"},{"key":"10.1007\/s13311-020-00897-4_bib90","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.parkreldis.2005.06.007","article-title":"Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's disease","volume":"11","author":"Asai","year":"2005","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib91","first-page":"1","article-title":"The effect of prucalopride on gastric emptying in Parkinson's disease patients, a pilot randomized, open-label study","volume":"1","author":"Pinyopornpanish","year":"2017","journal-title":"Digit Syst"},{"issue":"4","key":"10.1007\/s13311-020-00897-4_bib92","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.parkreldis.2011.01.007","article-title":"Botulinum toxin type A for the treatment of gastroparesis in Parkinson's disease patients","volume":"17","author":"Gil","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00897-4_bib93","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.parkreldis.2017.08.020","article-title":"Pilot cohort study of endoscopic botulinum neurotoxin injection in Parkinson's disease","volume":"44","author":"Triadafilopoulos","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib94","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.gastro.2016.03.038","article-title":"Relamorelin reduces vomiting frequency and severity and accelerates gastric emptying in adults with diabetic gastroparesis","volume":"151","author":"Lembo","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1007\/s13311-020-00897-4_bib95","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1053\/j.gastro.2017.07.035","article-title":"Efficacy and safety of relamorelin in diabetics with symptoms of gastroparesis: a randomized, placebo-controlled study","volume":"153","author":"Camilleri","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1007\/s13311-020-00897-4_bib96","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/pgmj.72.845.164","article-title":"Intestinal permeability and orocaecal transit time in elderly patients with Parkinson's disease","volume":"72","author":"Davies","year":"1996","journal-title":"Postgrad Med J"},{"key":"10.1007\/s13311-020-00897-4_bib97","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00702-015-1442-0","article-title":"Small intestine dysfunction in Parkinson's disease","volume":"122","author":"Dutkiewicz","year":"2015","journal-title":"J Neural Transm"},{"issue":"9","key":"10.1007\/s13311-020-00897-4_bib98","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/mds.25522","article-title":"The role of small intestinal bacterial overgrowth in Parkinson's disease","volume":"28","author":"Fasano","year":"2013","journal-title":"Mov Disord"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib99","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.parkreldis.2014.02.019","article-title":"Small intestinal bacterial overgrowth in Parkinson's disease","volume":"20","author":"Tan","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1007\/s13311-020-00897-4_bib100","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s00702-016-1612-8","article-title":"Prevalence of small intestinal bacterial overgrowth in Chinese patients with Parkinson's disease","volume":"123","author":"Niu","year":"2016","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1007\/s13311-020-00897-4_bib101","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.parkreldis.2018.04.003","article-title":"Small intestinal bacterial overgrowth in Parkinson's disease: tribulations of a trial","volume":"54","author":"Vizcarra","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"10.1007\/s13311-020-00897-4_bib102","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3233\/JPD-181386","article-title":"Weight loss in Parkinson's disease: no evidence for role of small intestinal bacterial overgrowth","volume":"8","author":"DiBaise","year":"2018","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib103","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/s41467-019-08294-y","article-title":"Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease","volume":"10","author":"van Kessel","year":"2019","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-020-00897-4_bib104","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0037-1601568","article-title":"Management of autonomic dysfunction in Parkinson's disease","volume":"37","author":"Pfeiffer","year":"2017","journal-title":"Semin Neurol"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mds.26866","article-title":"Constipation in Parkinson's disease: subjective symptoms, objective markers, and new perspectives","volume":"32","author":"Knudsen","year":"2017","journal-title":"Mov Disord"},{"issue":"20","key":"10.1007\/s13311-020-00897-4_bib106","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1007\/BF01798536","article-title":"Constipation in Parkinson's disease","volume":"69","author":"Jost","year":"1991","journal-title":"Klin Wochenschr"},{"issue":"21","key":"10.1007\/s13311-020-00897-4_bib107","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","article-title":"Medical records documentation of constipation preceding Parkinson disease: a case-control study","volume":"73","author":"Savica","year":"2009","journal-title":"Neurology"},{"key":"10.1007\/s13311-020-00897-4_bib108","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.parkreldis.2016.05.016","article-title":"Constipation and risk of Parkinson's disease: a Danish population-based cohort study","volume":"28","author":"Svensson","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1007\/s13311-020-00897-4_bib109","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.parkreldis.2014.09.026","article-title":"Risk of Parkinson's disease following severe constipation: a nationwide population-based cohort study","volume":"20","author":"Lin","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1007\/s13311-020-00897-4_bib110","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson's disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov Disord"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib111","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease. A review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"issue":"40","key":"10.1007\/s13311-020-00897-4_bib112","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.3748\/wjg.v18.i40.5812","article-title":"Treatment of recurrent sigmoid volvulus in Parkinson's disease by percutaneous endoscopic colostomy","volume":"18","author":"Toebosch","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib113","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4997\/jrcpe.2016.303","article-title":"Seven cases of sigmoid volvulus in Parkinson's disease","volume":"46","author":"Blackley","year":"2016","journal-title":"J R Coll Physicians Edinb"},{"issue":"s2","key":"10.1007\/s13311-020-00897-4_bib114","doi-asserted-by":"crossref","first-page":"S371","DOI":"10.3233\/JPD-191802","article-title":"Faecal transplantation, pro- and prebiotics in Parkinson's disease; hope or hype?","volume":"9","author":"Van Laar","year":"2019","journal-title":"J Parkinsons Dis"},{"issue":"12","key":"10.1007\/s13311-020-00897-4_bib115","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1212\/WNL.0000000000003127","article-title":"Probiotics and prebiotic fiber for constipation associated with Parkinson disease: an RCT","volume":"87","author":"Barichella","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib116","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/mdc3.12577","article-title":"Linaclotide and prucalopride for management of constipation in patients with parkinsonism","volume":"5","author":"Freitas","year":"2018","journal-title":"Mov Disord Clin Pract"},{"issue":"11","key":"10.1007\/s13311-020-00897-4_bib117","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/1756283X17734809","article-title":"An update on prucalopride in the treatment of chronic constipation","volume":"10","author":"Omer","year":"2017","journal-title":"Ther Adv Gastroenterol"},{"issue":"21","key":"10.1007\/s13311-020-00897-4_bib118","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182574f28","article-title":"Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease","volume":"78","author":"Ondo","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib119","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/jgs.13279","article-title":"Nizatidine ameliorates slow transit constipation in Parkinson's disease","volume":"63","author":"Sakakibara","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"10.1007\/s13311-020-00897-4_bib120","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.parkreldis.2017.02.003","article-title":"A randomized trial of relamorelin for constipation in Parkinson's disease (MOVE-PD): trial results and lessons learned","volume":"37","author":"Parkinson Study Group","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"10.1007\/s13311-020-00897-4_bib121","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.1983.03330330030012","article-title":"Pyridostigmine bromide and constipation in Parkinson's disease","volume":"249","author":"Sadjadpour","year":"1983","journal-title":"JAMA"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib122","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.parkreldis.2014.11.015","article-title":"Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease","volume":"21","author":"Pagano","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"13","key":"10.1007\/s13311-020-00897-4_bib123","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2340\/16501977-0456","article-title":"Functional magnetic stimulation in constipation associated with Parkinson's disease","volume":"41","author":"Chiu","year":"2009","journal-title":"J Rehabil Med"},{"key":"10.1007\/s13311-020-00897-4_bib124","first-page":"4842090","article-title":"Abdominal massage for the relief of constipation in people with Parkinson's: a qualitative study","volume":"2016","author":"McClurg","year":"2016","journal-title":"Parkinsons Dis"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib125","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1007\/s00415-012-6801-2","article-title":"Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms","volume":"260","author":"Cersosimo","year":"2013","journal-title":"J Neurol"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib126","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/jnnp.68.6.768","article-title":"Manometric investigation of anorectal function in early and late stage Parkinson's disease","volume":"68","author":"Bassotti","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1007\/s13311-020-00897-4_bib127","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.parkreldis.2011.06.002","article-title":"Levodopa ameliorated anorectal constipation in de novo Parkinson's disease: the QL-GAT study","volume":"17","author":"Tateno","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib128","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.410330512","article-title":"Defecatory function in Parkinson's disease: response to apomorphine","volume":"33","author":"Edwards","year":"1993","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib129","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1572-0241.2003.07514.x","article-title":"Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A","volume":"98","author":"Albanese","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1007\/s13311-020-00897-4_bib130","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/ner.12947","article-title":"Does bilateral deep brain stimulation of the subthalamic nucleus modify ano-rectal motility in Parkinson's disease? Results of a randomized cross-over study","volume":"22","author":"Gourcerol","year":"2019","journal-title":"Neuromodulation"},{"key":"10.1007\/s13311-020-00897-4_bib131","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.parkreldis.2016.10.024","article-title":"Lower urinary tract symptoms in Parkinson's disease: prevalence aetiology and management","volume":"35","author":"McDonald","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00897-4_bib132","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/WNF.0000000000000281","article-title":"Long-term outcome of adenosine A2A receptor antagonist on lower urinary tract symptoms in male Parkinson disease patients","volume":"41","author":"Kitta","year":"2018","journal-title":"Clin Neuropharmacol"},{"issue":"4","key":"10.1007\/s13311-020-00897-4_bib133","first-page":"1168","article-title":"Investigation of urinary storage symptoms in Parkinson's disease utilizing structural MRI techniques","volume":"38","author":"Roy","year":"2019","journal-title":"NeurourolUrodyn"},{"issue":"8","key":"10.1007\/s13311-020-00897-4_bib134","first-page":"2669","article-title":"Outcomes of intradetrusor onabotulinum toxin A ijection in patients with Parkinson's disease","volume":"37","author":"Vurture","year":"2018","journal-title":"NeurourolUrodyn"},{"key":"10.1007\/s13311-020-00897-4_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1756286419843458","article-title":"Feasibility of mirabegron in the treatment of overactive bladder in patients affected by Parkinson's disease: a pilot study","volume":"12","author":"Gubbiotti","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib136","first-page":"31","article-title":"Management of neurogenic bladder in patients with Parkinson's disease: a systematic review","volume":"38","author":"Hajebrahimi","year":"2019","journal-title":"NeurourolUrodyn"},{"issue":"11","key":"10.1007\/s13311-020-00897-4_bib137","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/mds.21586","article-title":"Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients","volume":"22","author":"Martinez-Martin","year":"2007","journal-title":"Mov Disord"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib138","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/mds.21813","article-title":"Nonmotor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study","volume":"23","author":"O'Sullivan","year":"2008","journal-title":"Mov Disord"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib139","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.nbd.2011.10.002","article-title":"Pathophysiology of bladder dysfunction in Parkinson's disease","volume":"46","author":"Sakakibara","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib140","first-page":"551","article-title":"A guideline for the management of bladder dysfunction in Parkinson's disease and other gait disorders","volume":"35","author":"Sakakibara","year":"2016","journal-title":"NeurourolUrodyn"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib141","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/mds.20867","article-title":"Bladder dysfunction in Parkinsonism: mechanisms, prevalence, symptoms, and management","volume":"21","author":"Winge","year":"2006","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-020-00897-4_bib142","series-title":"Parkinson's disease","first-page":"327","article-title":"Urological dysfunction","author":"Singer","year":"2013"},{"issue":"7","key":"10.1007\/s13311-020-00897-4_bib143","first-page":"1258","article-title":"Idiopathic Parkinson's disease patients at the urologic clinic","volume":"30","author":"Ragab","year":"2011","journal-title":"NeurourolUrodyn"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib144","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5213\/inj.1938086.043","article-title":"Urodynamic mechanisms underlying overactive bladder symptoms in patients with Parkinson disease","volume":"23","author":"Vurture","year":"2019","journal-title":"Int Neurourol J"},{"key":"10.1007\/s13311-020-00897-4_bib145","series-title":"Parkinson's disease and nonmotor dysfunction","first-page":"187","article-title":"Urological dysfunction","author":"Moore","year":"2013"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib146","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0022-5347(17)51929-1","article-title":"Neurourologic findings in Parkinson's disease","volume":"129","author":"Pavlakis","year":"1983","journal-title":"J Urol"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib147","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1464-410X.1983.tb03406.x","article-title":"Urethral sphincter abnormalities in Parkinsonism","volume":"55","author":"Galloway","year":"1983","journal-title":"Br J Urol"},{"issue":"11","key":"10.1007\/s13311-020-00897-4_bib148","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/iju.13792","article-title":"Parkinson's disease and prostate enlargement: both contribute to overactive bladder in the elderly","volume":"25","author":"Sakakibara","year":"2018","journal-title":"Int J Urol"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib149","first-page":"1737","article-title":"Behavioral therapy for urinary symptoms in Parkinson's disease: a randomized clinical trial","volume":"38","author":"Vaughan","year":"2019","journal-title":"NeurourolUrodyn"},{"issue":"13","key":"10.1007\/s13311-020-00897-4_bib150","doi-asserted-by":"crossref","first-page":"e1427","DOI":"10.1212\/WNL.0000000000008931","article-title":"Bladder training for urinary tract symptoms in PD: a randomized controlled trial","volume":"94","author":"McDonald","year":"2020","journal-title":"Neurology"},{"issue":"11","key":"10.1007\/s13311-020-00897-4_bib151","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/j.1742-1241.2008.01849.x","article-title":"Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin","volume":"62","author":"Kay","year":"2008","journal-title":"Int J Clin Pract"},{"issue":"10","key":"10.1007\/s13311-020-00897-4_bib152","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11940-016-0427-0","article-title":"Treatment options for urogenital dysfunction in Parkinson's disease","volume":"18","author":"Batla","year":"2016","journal-title":"Curr Treat Options Neurol"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib153","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.parkreldis.2015.02.025","article-title":"Non-Motor Working Group of the Parkinson Study Group (PSG). Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease","volume":"21","author":"Zesiewicz","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00897-4_bib154","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.parkreldis.2018.07.005","article-title":"Mirabegron in patients with Parkinson disease and overactive bladder symptoms: a retrospective cohort","volume":"57","author":"Peyronnet","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1007\/s13311-020-00897-4_bib155","doi-asserted-by":"crossref","first-page":"116625","DOI":"10.1016\/j.jns.2019.116625","article-title":"Extended release levodopa at bedtime as a treatment for nocturia in Parkinson's disease: an open label study","volume":"410","author":"Brusa","year":"2020","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1007\/s13311-020-00897-4_bib156","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.parkreldis.2010.06.006","article-title":"Use of botulinum toxin-A for the treatment of overactive bladder symptoms in patients with Parkinson's disease","volume":"16","author":"Kulaksizoglu","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib157","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.juro.2011.04.071","article-title":"Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder","volume":"186","author":"Giannantoni","year":"2011","journal-title":"J Urol"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib158","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034887","article-title":"Stimulation of the tibial nerve: a protocol for a multicentred randomised controlled trial for urinary problems associated with Parkinson's disease \u2013 STARTUP","volume":"10","author":"McClurg","year":"2020","journal-title":"BMJ Open"},{"issue":"7","key":"10.1007\/s13311-020-00897-4_bib159","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/ner.12446","article-title":"The impact of pallidal and subthalamic deep brain stimulation on urologic function in Parkinson's disease","volume":"19","author":"Mock","year":"2016","journal-title":"Neuromodulation"},{"key":"10.1007\/s13311-020-00897-4_bib160","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2147\/CIA.S204368","article-title":"Clinical study of the effects of deep brain stimulation on urinary dysfunctions in patients with Parkinson's disease","volume":"14","author":"Zong","year":"2019","journal-title":"Clin Interv Aging"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib161","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/jnnp.62.5.507","article-title":"Urodynamic and neurophysiological evaluation in Parkinson's disease and multiple system atrophy","volume":"62","author":"Stocchi","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib162","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/luts.12163","article-title":"Urethral sphincter injection of botulinum toxin A: a review of its application and outcomes","volume":"10","author":"Seth","year":"2018","journal-title":"Low Urin Tract Symptoms"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib163","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00702-016-1655-x","article-title":"Discussing sexuality with patients with Parkinson's disease: a survey among Dutch neurologists","volume":"124","author":"van Hees","year":"2017","journal-title":"J Neural Transm (Vienna)"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib164","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.parkreldis.2014.11.003","article-title":"Postural instability, the absence of sexual intercourse in the past month, and loss of libido are predictors of sexual dysfunction in Parkinson's disease","volume":"21","author":"Jitkritsadakul","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib165","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00002826-199010000-00008","article-title":"Sexual dysfunction in Parkinson's disease","volume":"13","author":"Koller","year":"1990","journal-title":"Clin Neuropharmacol"},{"issue":"Suppl 1","key":"10.1007\/s13311-020-00897-4_bib166","first-page":"S94","article-title":"Gastrointestinal, urological, and sexual dysfunction in Parkinson's disease","volume":"25","author":"Pfeiffer","year":"2010","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-020-00897-4_bib167","doi-asserted-by":"crossref","unstructured":"Shalash A, Hamid E, Elrassas H, Abushouk AI, Salem HH. Sexual dysfunction in male patients with Parkinson's disease: related factors and impact on quality of life. Neurol Sci 2020: https:\/\/doi.org\/10.1007\/s10072-020-04328-2.","DOI":"10.1007\/s10072-020-04328-2"},{"issue":"11","key":"10.1007\/s13311-020-00897-4_bib168","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s00415-015-7855-8","article-title":"Sexual dysfunction is associated with postural instability gait difficulty subtype of Parkinson's disease","volume":"262","author":"Deng","year":"2015","journal-title":"J Neurol"},{"issue":"4","key":"10.1007\/s13311-020-00897-4_bib169","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41443-018-0034-6","article-title":"Acquired premature ejaculation in Parkinson's disease and possible mechanisms","volume":"30","author":"Bronner","year":"2018","journal-title":"Int J Impot Res"},{"key":"10.1007\/s13311-020-00897-4_bib170","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2016.07.058","article-title":"Abnormal sexuality in Parkinson's disease: fact or fancy?","volume":"369","author":"Ferrucci","year":"2016","journal-title":"J Neurol Sci"},{"key":"10.1007\/s13311-020-00897-4_bib171","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jsxm.2018.12.017","article-title":"Parkinson's disease is associated with risk of sexual dysfunction in men but not in women: a systematic review and meta-analysis","volume":"16","author":"Zhao","year":"2019","journal-title":"J Sex Med"},{"key":"10.1007\/s13311-020-00897-4_bib172","doi-asserted-by":"crossref","first-page":"107493","DOI":"10.1016\/j.pharmthera.2020.107493","article-title":"Pharmacology and perspectives in erectile dysfunction in man","volume":"208","author":"Mitidieri","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib173","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/1531-8257(200003)15:2<305::AID-MDS1015>3.0.CO;2-W","article-title":"Sildenafil citrate (Viagra) for the treatment of erectile dysfunction in men with Parkinson's disease","volume":"15","author":"Zesiewicz","year":"2000","journal-title":"Mov Disord"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib174","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/jnnp.71.3.371","article-title":"Treatment of erectile dysfunction with sildenafil citrate (Viagra) in parkinsonism due to Parkinson's disease or multiple system atrophy with observations on orthostatic hypotension","volume":"71","author":"Hussain","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib175","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/mdc3.12456","article-title":"Sildenafil in the treatment of erectile dysfunction in Parkinson's disease","volume":"4","author":"Bernard","year":"2016","journal-title":"Mov Disord Clin Pract"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib176","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archneur.59.5.807","article-title":"Refractory nonmotor symptoms in male patients with Parkinson disease due to testosterone deficiency: a common unrecognized comorbidity","volume":"59","author":"Okun","year":"2002","journal-title":"Arch Neurol"},{"issue":"Suppl 3","key":"10.1007\/s13311-020-00897-4_bib177","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bcpt.12653","article-title":"Modulation of dopaminergic pathways to treat erectile dysfunction","volume":"119","author":"Simonsen","year":"2016","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib178","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mdc3.12561","article-title":"The role of sex therapy in the management of patients with Parkinson's disease","volume":"5","author":"Bronner","year":"2017","journal-title":"Mov Disord Clin Pract"},{"key":"10.1007\/s13311-020-00897-4_bib179","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-444-63247-0.00017-1","article-title":"Sexuality in patients with Parkinson's disease, Alzheimer's disease, and other dementias","volume":"130","author":"Bronner","year":"2015","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3233\/JPD-160926","article-title":"Sexual preoccupation behavior in Parkinson's disease","volume":"7","author":"Bronner","year":"2017","journal-title":"J Parkinsons Dis"},{"issue":"12","key":"10.1007\/s13311-020-00897-4_bib181","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1001\/jamaneurol.2014.1326","article-title":"Restless genital syndrome in Parkinson disease","volume":"71","author":"Aquino","year":"2014","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib182","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/mds.25379","article-title":"Acute genital pain during non-motor fluctuations improved by apomorphine","volume":"28","author":"Lefaucheur","year":"2013","journal-title":"Mov Disord"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib183","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mdc3.12425","article-title":"The skin and Parkinson's disease: review of clinical, diagnostic, and therapeutic issues","volume":"4","author":"Skorvanek","year":"2016","journal-title":"Mov Disord Clin Pract"},{"key":"10.1007\/s13311-020-00897-4_bib184","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/B978-0-444-64074-1.00043-4","article-title":"Thermoregulation in Parkinson disease","volume":"157","author":"Coon","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib185","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mds.26077","article-title":"The onset of nonmotor symptoms in Parkinson's disease (the ONSET PD study)","volume":"30","author":"Pont-Sunyer","year":"2015","journal-title":"Mov Disord"},{"issue":"2","key":"10.1007\/s13311-020-00897-4_bib186","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ana.410030207","article-title":"The hypothalamus in Parkinson disease","volume":"3","author":"Langston","year":"1978","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib187","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Arizona Parkinson's Disease Consortium. Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"8","key":"10.1007\/s13311-020-00897-4_bib188","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/mds.25776","article-title":"Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders","volume":"29","author":"Gelpi","year":"2014","journal-title":"Mov Disord"},{"key":"10.1007\/s13311-020-00897-4_bib189","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2016.04.045","article-title":"Hyperhidrosis associated with subthalamic deep brain stimulation in Parkinson's disease: insights into central autonomic functional anatomy","volume":"366","author":"Ramirez-Zamora","year":"2016","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1007\/s13311-020-00897-4_bib190","doi-asserted-by":"crossref","first-page":"6676","DOI":"10.4081\/ni.2016.6676","article-title":"Severe cold lower limbs in patients with Parkinson's disease during the summer","volume":"8","author":"Kataoka","year":"2016","journal-title":"Neurol Int"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib191","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00702-012-0884-x","article-title":"Temporal prolongation of decreased skin blood flow causes cold limbs in Parkinson's disease","volume":"120","author":"Shindo","year":"2013","journal-title":"J Neural Transm (Vienna)"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib192","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1212\/WNL.26.5.423","article-title":"Primary sensory symptoms in parkinsonism","volume":"26","author":"Snider","year":"1976","journal-title":"Neurology"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib193","first-page":"279","article-title":"Alterations of thermoregulation in Parkinson's disease","volume":"6","author":"De Marinis","year":"1991","journal-title":"Funct Neurol"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib194","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000116304","article-title":"Sweating dysfunction in Parkinson's disease","volume":"26","author":"Turkka","year":"1987","journal-title":"Eur Neurol"},{"issue":"12","key":"10.1007\/s13311-020-00897-4_bib195","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/mds.10586","article-title":"Sweating dysfunction in Parkinson's disease","volume":"18","author":"Swinn","year":"2003","journal-title":"Mov Disord"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib196","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archneurol.2009.71","article-title":"Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure","volume":"66","author":"Lipp","year":"2009","journal-title":"Arch Neurol"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib197","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/mds.21422","article-title":"Sweating in Parkinsonian patients with wearing-off","volume":"22","author":"Pursiainen","year":"2007","journal-title":"Mov Disord"},{"issue":"1","key":"10.1007\/s13311-020-00897-4_bib198","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/ana.410370124","article-title":"Drenching sweats as an off phenomenon in Parkinson's disease: treatment and relation to plasma levodopa profile","volume":"37","author":"Sage","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-020-00897-4_bib199","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1007\/s00415-019-09325-w","article-title":"Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson's disease","volume":"266","author":"van Wamelen","year":"2019","journal-title":"J Neurol"},{"issue":"4","key":"10.1007\/s13311-020-00897-4_bib200","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archinte.1991.00400040130031","article-title":"Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy","volume":"151","author":"Keyser","year":"1991","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib201","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1353-8020(02)00035-4","article-title":"Neuroleptic malignant syndrome-like, or \u2013 dopaminergic malignant syndrome \u2013 due to levodopa therapy withdrawal. Clinical features in 11 patients","volume":"9","author":"Serrano-Duenas","year":"2003","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1007\/s13311-020-00897-4_bib202","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/mds.20380","article-title":"Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance","volume":"20","author":"Ladha","year":"2005","journal-title":"Mov Disord"},{"issue":"9","key":"10.1007\/s13311-020-00897-4_bib203","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1345\/aph.1P242","article-title":"An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay","volume":"44","author":"Bonnici","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1007\/s13311-020-00897-4_bib204","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0897190015627530","article-title":"Levodopa withdrawal presenting as fever in a critically ill patient receiving concomitant enteral nutrition","volume":"29","author":"Whitman","year":"2016","journal-title":"J Pharm Pract"},{"issue":"4","key":"10.1007\/s13311-020-00897-4_bib205","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/mds.870040408","article-title":"\u201cOn-off\u201d-induced lethal hyperthermia","volume":"4","author":"Pfeiffer","year":"1989","journal-title":"Mov Disord"},{"issue":"3","key":"10.1007\/s13311-020-00897-4_bib206","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clineuro.2009.11.015","article-title":"Effects of subthalamic nucleus deep brain stimulation on sweating function in Parkinson's disease","volume":"112","author":"Trachani","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"issue":"1-2","key":"10.1007\/s13311-020-00897-4_bib207","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jns.2009.06.019","article-title":"Alleviation of drenching sweats following subthalamic deep brain stimulation in a patient with Parkinson's disease \u2013 a case report","volume":"285","author":"Sanghera","year":"2009","journal-title":"J Neurol Sci"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00897-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-020-00897-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923012539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-020-00897-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:04:20Z","timestamp":1761807860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923012539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":207,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1878747923012539"],"URL":"https:\/\/doi.org\/10.1007\/s13311-020-00897-4","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autonomic Dysfunction in Parkinson's Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-020-00897-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}